113 related articles for article (PubMed ID: 8562156)
1. Primary central nervous system lymphoma: treatment with chemotherapy and radiotherapy.
Sarazin M; Ameri A; Monjour A; Nibio A; Poisson M; Delattre JY
Eur J Cancer; 1995 Nov; 31A(12):2003-7. PubMed ID: 8562156
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients.
Ferreri AJ; Reni M; Dell'Oro S; Ciceri F; Bernardi M; Camba L; Ponzoni M; Terreni MR; Tomirotti M; Spina M; Villa E
Oncology; 2001; 60(2):134-40. PubMed ID: 11244328
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with high-dose methotrexate and cytarabine with or without brain irradiation for primary central nervous system lymphomas.
Calderoni A; Aebi S
J Neurooncol; 2002 Sep; 59(3):227-30. PubMed ID: 12241119
[TBL] [Abstract][Full Text] [Related]
5. Combined therapy for primary central nervous system lymphoma in immunocompetent patients.
Ferreri AJ; Reni M; Bolognesi A; Verusio C; Villa E
Eur J Cancer; 1995 Nov; 31A(12):2008-12. PubMed ID: 8562157
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients.
Freilich RJ; Delattre JY; Monjour A; DeAngelis LM
Neurology; 1996 Feb; 46(2):435-9. PubMed ID: 8614508
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of non-Hodgkin's lymphoma of the central nervous system with BMPD chemotherapy followed by radiotherapy.
Korfel A; Thiel E
Leuk Lymphoma; 1998 Aug; 30(5-6):609-17. PubMed ID: 9711923
[TBL] [Abstract][Full Text] [Related]
8. Treatment for primary CNS lymphoma: the next step.
Abrey LE; Yahalom J; DeAngelis LM
J Clin Oncol; 2000 Sep; 18(17):3144-50. PubMed ID: 10963643
[TBL] [Abstract][Full Text] [Related]
9. Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete follow-up.
Omuro AM; DeAngelis LM; Yahalom J; Abrey LE
Neurology; 2005 Jan; 64(1):69-74. PubMed ID: 15642906
[TBL] [Abstract][Full Text] [Related]
10. Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy.
DeAngelis LM; Yahalom J; Heinemann MH; Cirrincione C; Thaler HT; Krol G
Neurology; 1990 Jan; 40(1):80-6. PubMed ID: 2296388
[TBL] [Abstract][Full Text] [Related]
11. A single-center study of 11 patients with intraocular lymphoma treated with conventional chemotherapy followed by high-dose chemotherapy and autologous bone marrow transplantation in 5 cases.
Soussain C; Merle-Béral H; Reux I; Sutton L; Fardeau C; Gerber S; Ben Othman T; Binet JL; Lehoang P; Leblond V
Leuk Lymphoma; 1996 Oct; 23(3-4):339-45. PubMed ID: 9031115
[TBL] [Abstract][Full Text] [Related]
12. Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy.
Bessell EM; Graus F; Punt JA; Firth JL; Hope DT; Moloney AJ; Lopez-Guillermo A; Villa S
J Clin Oncol; 1996 Mar; 14(3):945-54. PubMed ID: 8622044
[TBL] [Abstract][Full Text] [Related]
13. Primary non-Hodgkin's lymphoma of bone. A clinicopathologic study.
Baar J; Burkes RL; Bell R; Blackstein ME; Fernandes B; Langer F
Cancer; 1994 Feb; 73(4):1194-9. PubMed ID: 8313322
[TBL] [Abstract][Full Text] [Related]
14. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.
Cheng T; Forsyth P; Chaudhry A; Morris D; Glück S; Russell JA; Stewart DA
Bone Marrow Transplant; 2003 Apr; 31(8):679-85. PubMed ID: 12692608
[TBL] [Abstract][Full Text] [Related]
15. Outcome and patterns of failure in testicular lymphoma: a multicenter Rare Cancer Network study.
Zouhair A; Weber D; Belkacémi Y; Ketterer N; Dietrich PY; Villà S; Scandolaro L; Bieri S; Studer G; Delacretaz F; Girardet C; Mirimanoff RO; Ozsahin M;
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):652-6. PubMed ID: 11849786
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system relapse of systemic non-Hodgkin's lymphoma: results of treatment based on high-dose methotrexate combination chemotherapy.
Bokstein F; Lossos A; Lossos IS; Siegal T
Leuk Lymphoma; 2002 Mar; 43(3):587-93. PubMed ID: 12002763
[TBL] [Abstract][Full Text] [Related]
17. Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?
O'Neill BP; O'Fallon JR; Earle JD; Colgan JP; Brown LD; Krigel RL
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):663-73. PubMed ID: 7558957
[TBL] [Abstract][Full Text] [Related]
18. Multi-modality therapy leads to longer survival in primary central nervous system lymphoma patients.
Singhal D; Witham TF; Germanwala A; Flickinger JC; Schiff D; Kondziolka D
Can J Neurol Sci; 2002 May; 29(2):147-53. PubMed ID: 12035835
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma.
Tomita N; Kodama F; Kanamori H; Motomura S; Ishigatsubo Y
Cancer; 2002 Aug; 95(3):576-80. PubMed ID: 12209750
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
Hoang-Xuan K; Taillandier L; Chinot O; Soubeyran P; Bogdhan U; Hildebrand J; Frenay M; De Beule N; Delattre JY; Baron B;
J Clin Oncol; 2003 Jul; 21(14):2726-31. PubMed ID: 12860951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
